Method for treating leukemias using N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide for treating leukemias and solid tumors
AssigneeLaboratories Knoll, S.A.
InventorsMiguel F. Brana, Antonio M. Sanz, Rafael P. Alvarez-Ossorio, Cristobal M. Roldan, Cristina R. F. De Gamboa, Jesus G. Garcia, Jose M. C. Berlanga
Life of this patent
Estimating the term…
Abstract
N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide (amonafide) is an effective agent for the treatment of leukemias and solid tumors.
Claims6
A method of treating a patient with leukemia, comprising administering to said patient a chemotherapeutically effective amount of N-( 2-dimethylaminoethyl)-3-amino-1,8-naphthalimide.
A method of treating a patient with p388 leukemia or L-1210 leukemia, comprising administering to said patient a chemotherapeutically effective amount for treatment of p388 leukemia or L-1210 leukemia of N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide.
Dependencies are inferred from the claim text.